Obesity Trial, Recruiting NCT07120802 Sponsor: Harokopio University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07120802
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years of age
  • People with a BMI of 25 or above (considered overweight or obese), or people with a BMI between 18.5 and 24.9 (considered normal weight)
  • People who are willing and able to use a wearable device and a mobile app on an Android phone for the full length of the study
  • People who own a smartphone that runs the Android operating system
  • People whose dominant hand movements when eating match the gestures used with a fork or spoon
  • People who can read and understand the language used in the app and study materials
  • People who are willing to give their formal agreement to take part in the study
  • People who currently live in one of the seven countries taking part in the trial (confirm with trial site for the list of countries)
  • People who are available and able to take part for the full three-week study period and follow the study procedures

Who may not be able to join:

  • People who are currently pregnant or breastfeeding
  • People who have a physical or mental health condition that would prevent them from using the wearable device or mobile app as the study requires
  • People who regularly or daily use chopsticks to eat
  • People who do not own a compatible Android smartphone, or whose devices are not technically compatible with the study's wearable equipment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yannis Manios, Professor, Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece

Phone: 2109549156

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Harokopio University
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
30 September 2025

Where this trial is recruiting

Cyprus 🇫🇷 France 🇬🇷 Greece 🇵🇱 Poland 🇵🇹 Portugal 🇪🇸 Spain 🇸🇪 Sweden

Primary endpoints

System Usability Scale (SUS) Score - End-Users; System Usability Scale (SUS) Score - Implementers; Acceptability of Intervention Measure (AIM) Score - End-Users; AIM Score - Implementers; Feasibility of Intervention Measure (FIM) Score - End-Users; FIM Score - Implementers; Intervention Appropriateness Measure (IAM) Score - End-Users; IAM Score - Implementers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov